
Ubigene gene knockout cell lines mediated by optimized CRISPR-Cas9 technology provide reliable in vitro models for investigating gene function, signaling pathways, disease mechanisms, and therapeutic targets.
ZDHHC17 (zDHHC palmitoyltransferase 17) encodes a DHHC family protein-cysteine S-palmitoyltransferase that catalyzes protein palmitoylation. Localized primarily to the Golgi membrane and Golgi-associated vesicles, ZDHHC17 contributes to lipid modification of proteins and is involved in lipoprotein transport and regulation of programmed cell death. Its enzymatic activity helps regulate protein localization and function through reversible palmitoylation.
A human hepatocellular carcinoma cell line of Japanese origin, established from the liver tumor of a 57-year-old male patient. The cells are classified as an adult hepatocellular carcinoma line and have been extensively characterized for their molecular and genetic properties. The cell line exhibits a predominantly East Asian genomic ancestry profile and carries documented sequence variations affecting genes including KDR, POLD3, TERT, and TP53.
Comprehensive quality control includes STR authentication, sterility testing (bacteria and fungi), and mycoplasma screening to ensure purity and performance. Genotype is confirmed by two rounds of PCR and Sanger sequencing, and complete validation reports are provided for make-to-order products.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.

Targeted knockout region: EExon 2
Reference Transcript: NM_015336
Frameshift Mutation Strategy
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use





Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours.
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?